Effects of pioglitazone on major adverse cardiovascular events in high-risk patients with type 2 diabetes: results from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive 10)

    American heart journal, Volume 155, Issue 4, 2008, Pages 712-717.

    Cited by: 46|Bibtex|Views1|Links
    WOS EI
    Keywords:
    clinical trial

    Abstract:

    Composite end points of major adverse cardiovascular events (MACEs) are standard measures for comparing treatment in large cardiovascular outcome studies. This analysis from PROspective pioglitAzone Clinical Trial In macro Vascular Events (PROactive) evaluated the effects of pioglitazone on the prespecified MACE end point of cardiovascula...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments